Diabetic Macular Edema (DME) Withdrawn Phase 4 Trials for Bevacizumab (DB00112)

Also known as: Diabetic Macular Edema(DME) / Diabetic Macular Oedema / Macular Edema, Diabetic / Diabetic Macular Edema / Macular edema due to diabetes mellitus (disorder) / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Withdrawn4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00496405Unilateral Bevacizumab for Bilateral Diabetic Macular EdemaOther